Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma

Mahdi, Haider

404
Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma

Sunday, March 29, 2015: 7:00 AM

Salon C-D (Hilton Chicago)

H. Mahdi¹, P. G. Rose¹, M. Elshaikh², A. R. Munkarah², D. Isrow², S. Singh³, S. E. Waggoner³, R. Ali-Fehmi⁴, J. Harding⁵, R. T. Morris⁶ and R. DeBernardo¹
¹Cleveland Clinic, Cleveland, OH, ²Henry Ford Health System, Detroit, MI, ³University Hospitals Case Medical Center, Cleveland, OH, ⁴Wayne State University, Detroit, MI, ⁵Case Western Reserve Univesity, Cleveland, OH, ⁶Wayne State University School of Medicine, Detroit, MI

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

404
Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma

404 Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma

404
Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma